Nektar Therapeutics (NKTR) Stock: Spiraling Down On Clinical Data

Nektar Therapeutics (NASDAQ: NKTR) is having an overwhelmingly rough start to the trading session this morning after the company released data from a clinical trial. The underwhelming data is leading to fear among investors, sending the stock spiraling out of control. Today, we’ll talk about: The clinical data; what we’re seeing from the stock; and … Read more

Nektar Therapeutics (NKTR) Stock: Gains Big On Strong Clinical Data

Nektar Therapeutics (NASDAQ: NKTR) Nektar Therapeutics is having an overwhelmingly strong time in the pre-market trading hours this morning, and for good reason. Early this morning, data was released with regard to a clinical study that proved to be overwhelmingly positive. Below, we’ll talk about that data, how the stock is reacting to the news, … Read more

Biggest Gainers In Biotech Tech Today | Synergy Pharmaceuticals (SGYP) | Catalyst Pharmaceutical Partners (CPRX) | Rockwell Medical (RMTI) | Vanda Pharmaceuticals (VNDA) | Nektar Therapeutics (NKTR)

Today hasn’t been the best day for US stocks; especially in the biotech space. Unfortunately, when looking at the biotech sector, we’re seeing a sea of red. However, there are a few stocks that are doing well regardless of today’s conditions in the market. Here are some of the biggest gainers in biotech today and … Read more